SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-018381
Filing Date
2021-09-10
Accepted
2021-09-10 16:04:20
Documents
15
Period of Report
2021-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20210910.htm   iXBRL 8-K 47205
2 EX-99.1 a991_x4pharmaceuticalsprom.htm EX-99.1 13469
6 image_0.jpg GRAPHIC 69
7 image_2.jpg GRAPHIC 6316
  Complete submission text file 0001628280-21-018381.txt   224544

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20210910.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20210910_lab.xml EX-101.LAB 25998
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20210910_pre.xml EX-101.PRE 13731
8 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20210910_htm.xml XML 12212
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 211247106
SIC: 2836 Biological Products, (No Diagnostic Substances)